Protocol for the Treatment of Prostate Cancer Dr. Serge Jurasunas

Professor of Naturopathic Oncology

Serge Jurasunas is an internationally well known figure and pioneer in

Naturopathic medicine, iridology, nutrition, complementary oncology, live

blood analysis (LBA) with 50 years of practice and experience in treating

chronic and degenerative disease and cancer. At the same time he

developed several innovative therapies. By studying both conventional

oncology and alternative medical science he has better understood the

advantages and failures of what we can expect from both perspectives.

Over the past decades he directed several clinics treating patients coming

from many countries but also has welcomed many doctors and physicians

coming to learn about his methods of cancer treatment. Today he both

teaches and collaborates with oncologists, medical doctors and researchers,

inviting them to join in and share mutual experience and knowledge and to

proliferate CAM methods both to practitioners and the public.

Lectures on Complementary Oncology

The work of professor Serge Jurasunas has become well known around

the world after having traveled and lectured in 40 countries in the field of

New Avenues of Cancer Treatment. He has attracted the interest of

Universities and was invited by the University of Vilnius (Lithuania)

Faculty of Medicine to deliver a seminar on “New Avenues and Treatment

in Oncology”, with a audience of about 300 doctors, oncologists,

immunologists, a rare privilege to introduce alternative cancer treatment

with the presentation of clinical cases to a Faculty of Medicine.

More recently he delivered a lecture on Molecular Markers in Cancer

Diagnostics and Therapy at the 2th International Congress on

Complementary Oncology in Munich, invited by the German Society of

Oncology.

The Molecular Basis of Cancer

New Paradigm

Serge Jurasunas is now deeply involved in the research and clinical

application of molecular markers, tumor suppressor genes and oncogenes

associated with cancer initiation, promotion and cancer development,

having spent about 10 years in the study and clinical application of

molecular markers testing with cancer patients before and after treatment,

with follow up, over periods lasting up to 4 years.

This approach facilitates better understanding of the genetic mechanism in

the disease of cancer, to check on resistant cancer cells, to make a

prognostic for each patient as well as customized selection of dietary

agents and other anticancer agents according to individual results. This

affirms the great advantage of personalized medicine that seems to be a

better response to cancer treatment since no two patients have the same

tumor suppressors and oncogene activity and therefore may have a good or

poor result with chemotherapy\radiation. Also it permits us to predict

disease recurrence which is one of the failures of medicine. Correct

assessment is the first and most crucial step in the evaluation of the patient

with prostate cancer, however the modern conventional diagnosis that

includes laboratory testing and imaging, bone scan or other alternative

system is far from complete and does not provide a real basis for the

molecular gene aspect.

Publication of a Paper on Molecular Markers

Professor Serge Jurasunas is a frequent contributor to the Townsend Letter,

The Examiner of Alternative Medicine (USA) , having written articles on

cancer disease, clinical cases and molecular markers. The last article was,

“The Molecular Basis of Prostate Cancer and Targeting Therapies”, to be

published in the special Cancer Issue of August/September 2017, available

on request after publication.

“New Theories and Advances in Cancer Treatment”, is also available

from Slideshare. This article offers a wide range of details about prostate

cancer and the implication of tumor suppressor genes and oncogenes,

along with complete details about the effect of each anticancer agent or

dietary agent. It both documents and explains about what a patient can

really expect from conventional medicine, surgery, chemotherapy,

radiation or hormonotherapy. I offer further information on what to expect

from our protocol on prostate cancer which we have defined over the

years and that has demonstrated efficiency even with advanced cases of

prostate cancer with bone metastases.

Prostate Cancer

Disease States

Prostate cancer has become the #1 killer in men, even now before lung

cancer. When prostate cancer is diagnosed in about 50% of these cases it

can be expected that the disease will progress to an incurable stage. While

it is true that most prostate cancers are unsymptomatic and slow growing,

one third of the cases are more aggressive and fast developing. Prostate

metastases spreads relatively quickly to other parts of the body,

particularly lymph nodes, rectum, bones and brain. Hypoxia occurs in 30%

or 40% of prostate cancers which in turn increases angiogenic factors and

upregulates the P53 tumor suppressor gene that triggers apoptosis or the

death of cancer cells.

Conventional treatment includes a combination of surgery, chemotherapy,

radiation, hormonotherapy that may be effective for localized disease but

there is no effective treatment strategy for metastasized prostate cancer

which remains painful and incurable. Despite advances in local treatment,

approximately 25% of radically treated patients will develop disease

progression and 10% to 20% of the cases present at primary diagnostic

develop bone metastases. Chemotherapy could only extend the lives of

patients by months or few years at most.

Metastatic Prostate Cancer with Bone Metastases

One year survival: 87%

Five year survival: 56%

Metastatic Prostate cancer with Bone and Skeletal

Involvement

One year survival: 40%

Five year survival: less than 1%

What Can be Done to Improve this Situation

Therefore prostate cancer must be treated immediately in the beginning

with a complementary approach to avoid the spread of metastases in the

body. Many cases are hormone refractory, meaning they don't respond any

more neither to hormonal therapy and more often than not to

chemotherapy or radiation leaving the patient without solution. Secondly

advanced prostate cancer with bone and skeleton metastases no longer

benefits from chemotherapy and needs some alternative solution. As

explained in my document, “Integrative Cancer, New Theories and

Advances in Treatment”, more chemotherapy renders cancer cells more

resistant to destruction by apoptosis and contributes to making the disease

even worse, weakening more the patient. Also see in my new blog:

Https://naturopathiconcology.blogspot.com my new posting: "WHAT IS

CANCER". This may better explain the mechanism of the disease and

how to handle the patient. The article focuses on a new strategy of

anticancer treatment based on new rediscoveries of science concerning the

metabolic aspects of the disease according to the past research of Otto

Warburg on cellular respiration.

Cancer Cells are Tested for Genetic Markers

68 Year Old Patient

As an example in one non cancer patient, the husband of a women I was

treating for breast recurrence, a very nervous man (see the test above) we

detected a very high expressed survivin at 51.548 ul/ml of plasma. He was

lucky that the Bax gene expression was highly active at 81,699 units/ml of

plasma, where apoptosis was really functioning via this channel as a

defense to kill as many cancer cells as possible, but further showing that it

was already a tumor condition.

In fact with our treatment the second test showed that survivin gene

expression dramatically decreased to 105 units/ml of plasma. It was really

a performance decreasing this level using a combination of dietary agents.

However we had done the Tumor Marker-2-Pyruvate Kinase (TM-2-

Pyruvate Kinase) activity (unfortunately not at the first test) that really

showed a very high metabolic tumor activity, 142 units/ml of plasma. This

could have been higher before and decreased since I saw the case as high

as 290 units/ml of plasma or even 350 units/ml of plasma.(5-15 units is the

reference.)

Now the TM-2-PK activity decreased to 49.2 units/ml of plasma which is

excellent and survivin gene expression to 30 units/ml of plasma. So we

had the following: 51.548 - 105 – 30 units/ ml of plasma.

Later on the patient was finally diagnosed with a prostate tumor and

scheduled for surgery but in the meantime he kept taking our treatment

regimen and when he came into the hospital, during the surgery the

surgeon found no trace of a tumor. This is a true story. Another case of

advanced prostate cancer with bone metastasis.

In our clinic, cancer patients are tested for genetic markers such as the

P53 tumor suppressor gene known as the guardian of our genome. P53

mutation or defects appear necessary in cancer development, growth and

invasion. We look at Bax, an proapoptotic gene, BcL2, survivin, P21,

VEGF and others. Some oncogenes and inhibitors of apoptosis such the

BcL2 and survivin are usually overexpressed in prostate cancer increasing

the resistance of cancer cells. The ratio BcL2/Bax determines the quantity

of cancer cells destroyed through apoptosis. Survivin is a inhibitor of

apoptosis that can be detected only in cancer tissue. Meaning you can

detect the disease even before laboratory test. As an example in one non

cancer patient we detected a very high expressed survivin of 54.560 ul/ml

of plasma while the reference range is10 ul/ml meaning it was already a

advanced tumor but the patient didn't know about it. Another case of

advanced prostate cancer with bone metastasis had a PSA at 680 ng/ml,

very poor condition and our blood testing showed a very high survivin

activity of 24210 ul/ml of plasma and mutated P53.

After our treatment survivin dramatically decreased to 8 ul/ml of plasma

and we reversed the P53 mutation to a normal protein although with low

activity while PSA after one month decreased to 380 ng/ml and later on to

54 ng/ml. Such testing allows for individual and personalized treatment

base on the results of the test and using selected dietary agents,

phytotherapy, orthomolecular medicine and other anticancer agents

appropriate to prostate cancer cells that in turn increase apoptosis, inhibit

angiogenesis, increase immune defense and shoot down tumor growth.

Thanks to the research done by Prof. Serge Jurasunas who devoted

considerable time in scientific investigation and work to develop new

formulas like a curcumin in liquid with a very high absorption rate in his

own pharmaceutical laboratory.

Serge Jurasunas' Natural Medicine

For years Serge Jurasunas has accumulated enough clinical experience and

knowledge working with over 150,000 patients using all kinds of diet,

therapies from different sources enabling him to build his own Natural

Medicine Therapy. In relation to cancer treatment, Professor Serge

Jurasunas' methodology made a bridge between Naturopathic medicine

and Molecular medicine which permits treating the disease and the whole

body simultaneously. We know that some natural foods can change gene

expression and that many dietary agents like curcumin for instance can

target several mechanisms associated with cancer development and cancer

growth. Over the past decades Serge Jurasunas has researched a number

of dietary agents to see how they can modified tumor suppressor genes and

oncogenes after performing molecular markers testing. After several years

of observation with several hundred cancer cases he began to select some

dietary agents and other anticancer compounds that work in synergy and

offer better results leading some patients to complete remission or life span

extension, even when the disease was far advanced. These include

curcumin, resveratrol, genistein, pomegranate, Betacyanin (red beet) green

and black propolis, chorella extract, fish peptides, thymus extract, ginseng

extract, Omega3 and selenium.

Of course in our clinic we handle all types and grades of cancer and that

include prostate cancer along with most cases with bone and skeleton

metastases, ranging from a low to high PSA level that can be over 1200

ul\ml.

Between 5/2006 to 6/2007 PSA Declines from 1260 to 1.58

As an example we have the case of a 73 year old man diagnosed in

September, 2005 with a prostate cancer with metastases, disseminated

throughout the skeleton. In May, 2006 he came to me in bad physical

condition. PSA at 1260, no surgery, chemotherapy or radiation was

suggested by doctors. Only a hormonal therapy but without visible result.

After 4 months of our treatment the patient considerably improved

physically and feel happy. PSA decreased to 328 and after 8 months to 58

and finally to 2.8 and 1.58 after one year. After 6 months 50% of the bone

metastases was eliminated and after one year total elimination. The patient

is in remission with a good quality of life. Other cases are available on

www.sergejurasunas.com , include a taxi driver also with an advanced

prostate cancer who with no conventional treatment was cured after one

year, free from all the skeletal metastases. We followed him for more than

a 10 year period.

New Protocol for Prostate Cancer

Recently Serge Jurasunas has defined a new treatment for prostate cancer

by including new anticancer agents that he had researched and tested for a

period of 2 years, obtaining remarkable results confirmed by molecular

markers testing on patients before, during and after treatment. It also

showed a decreased PSA level and either reduction or elimination of tumor

and bone metastases. But some other anti-cancer agents have been utilized

for nearly 30 years for different types of cancer. Many results from clinical

cases were published over the past 18 years in the Townsend Letter, The

Examiner of Alternative Medicine (USA).

How to Approach Prostate Cancer

Cancer must be approached in several directions at same time that include

the following process which is considered as an important Hallmark of

Cancer.

Diagnostic and prognostic Factors

1. Apoptosis (One's own killing of cancer cells)

2. Angiogenesis (VEGF FGF)

3. Tumor suppressor (TGFB, cMyc, P53)

4. Oncogenes (BcL2 Survivin)

5. Inflammation (NF Kappa B, Cox2)

6. Immune modulation (NK cells Dendritic cells, T cells, B cells,

Macrophages)

Other factors can include blood parameters such as anemia, candida

growth, balancing the microbiome and strengthening the nervous system

since there is a relationship between the nervous system and the activation

of the Natural Killer Cells (N.K.Cells).

Suggested Protocol

This protocol is adapted to respond to the 6 Hallmarks of Cancer and has

shown efficacy in targeting the oncogene BcL2 and the inhibitor of

apoptosis survivin, both overexpressed in prostate cancer and responsible

for cancer cell resistance to chemotherapy and radiation.

Tegaran: Made from fermented soy that contains phytic acid, protease

inhibitors, saponins,phytosterols and genistein, that all in vitro and in vivo

tests and clinical studies have confirmed the positive effects of the

ingredients of the fermented soy extract in therapeutic approaches for

adjuvant treatment of solid tumor. Tegaran targets most of the molecular

aspect of cancer development and growth including apoptosis,

angiogenesis, immune system, inflammation and drug resistance.

Curcumin: An important dietary agent that acts by blocking the different

stage of cancer and inhibiting malignant cell proliferation during the

promotion and progression of prostate cancer. Curcumin acts on most of

the genes implicated in cancer. In prostate cancer curcumin has shown

efficacy to increase the destruction of cancer cells by halting the cell cycle

phase at G2 or M and sensitizes tumor cells to various antineoplasic

agents. Curcumin targets the oncogene BcL2 and survivin and increasing

P53 function, therefore triggering apoptosis and decreasing resistance of

cancer cells to chemotherapy and radiation. It's important to note

curcumin inhibits NF Kappa B, an inflammatory mediator that stimulates

most of the mechanisms associated with tumor growth, progression and

resistance to anticancer drugs. Curcumin is difficult to absorb through the

intestine and cells. This is why Serge Jurasunas developed a new formula

of liquid curcumin that is rapidly absorbed by the intestine and the cells,

which is manufactured in his own Pharmaceutical Laboratory in Portugal.

Biobran (Biological Response Modifier)

We now have used biobran for over 2 decades, an important

immunomodulator with anticancer properties. Biobran is a arabinoxylan

compound extracted out of rice bran cultivated on shitake enzyme and has

shown to have dramatic effects on our front line soldiers in the immune

system that work against cancer. It includes NK cells, dendritic cells and

macrophages. NK cells play an important function in the primary host

defense against cancer where defective NK cells function is associated

with various malignancies. Most cancer patients have a defective immune

system functioning from 0% to 30% compared to a healthy person. The

NK cells are here but not activated to release their toxic enzymes to

destroy cancer cells through apoptosis cellular activity, which subsequently

is increased 60% after 2 weeks with a daily dose of 2gr of Biobran. Then if

you continue you can achieve up to 200% and 300% NK cell number and

activity. Biobran has demonstrated efficacy to kill cancer cells either by

apoptosis or lysis and has a dramatic effect on prostate cancer especially

when prescribed in synergy with curcumin. Biobran Mgn3 is much more

powerful than any other arabynoxylan or mushroom extract found on the

market. We also found a synergistic effect when using both curcumin and

Biobran Mgn3 on apoptosis and tumor inhibition. Biobran Mgn3 and

curcumin modulate BcL2/Bax ratio by up-regulating the Bax gene and

down regulating the BcL2 oncogene, therefore increasing the death of

cancer cells through apoptosis and of course it increases the effectiveness

of chemotherapy. Even alone Biobran/Mgn3 and curcumin can reduce

tumor size. My new conference presentation that will be delivered on June

2017 at the 5th International Workshop Biobran in Krakow, Poland, will

fully explain the synergistic effect of these 2 compounds along with

several cases of cancer patients including Prostate cancer, using this

protocol. The lecture, “A New Modern Way to Approach Cancer” will be

available on slideshare. (or contact the author)

Prae Cell

This is a formula especially developed for prostate cancer that contains

fermented soy (same formula as Tegaran), lycopene from tomatoes, zinc,

selenium, vitamin D3 which is particularly efficient to treat prostate

cancer.

Detoxification

Detoxification is also a very important step in treating any disease,

especially cancer. Most people are intoxicated from bad dietary style,

excess of food, constipation and by an excess of industrial foods that

produce endogenous toxins, along with exogenous toxins from the

environment. We found 700 chemicals in drinking water, 3000 chemicals

in food and 10,000 chemicals in processed foods , fertilizers, pesticides

that their use continues to increase.

Colon intoxication from constipation especially in case of prostate cancer

cannot be minimized. According to Dr. Joseph Brenner, Oncologist not

only do people already have already excess of toxins when cancer is first

diagnosed but the amount of toxins increase due to the toxic drugs and the

breakdown of tumors that poison the body which overtax the liver. The

intestinal microbiome , called micro-flora is also critical to increase the

immune defense and today attracts more attention from science especially

today in reference in cancer treatment..

Therefore Dr. Joseph Brenner suggests like I have done for so many years

colon cleansing, diet, and mini fasting. Also you can learn more by

reading my new book, “Health and Disease Begin in the Colon,

Featuring Professor Serge Jurasunas' Natural Medicine”, a 350 page

book with over 100 figures and color photographs with special chapters

about the microbiome, how to detox, healing food, diet, some important

supplements, auto-intoxication of the colon and dramatic clinical cases

(Available on Amazon).

Active Detox

To activate detoxification and reinforce the treatment this is a excellent

formula made from coriander, chorella cell peptide, spinach, green tea,

extract of rosemary, brassica (from broccoli) N-Acetyl Cysteine,

methionine, zinc and selenium which are all important for prostate cancer.

1- Case of earlier prostate cancer (or hypertrophy,higher PSA level)

Prae cell, curcumin,biobran,pomegranate, green propolis, Active Detox.

2- Case of prostate cancer with bone metastases, advanced disease

Treatment:

Tegaran, curcumin, Biobran, Prae cell, Active detox. Green propolis

However even with localized prostate cancer patient can take Tegaran if

the PSA is still increasing and combine it with Biobran. There is a

synergistic effect of Biobran with curcumin but also Genistein and

curcuma so it shows that we really have worked with the best

combinations. The advice of a physician is sometimes required and

patients can come to our clinic for a personal consultation or they can have

a consultation by phone, email or Skype for personalized treatment, diet

and nutritional advice. To learn more about prostate cancer as I have said

before read my new article to be published in Townsend Letter, The

Examiner of Alternative medicine (USA) or contact me below:

Dr. Serge Jurasunas explaining the result of a molecular markers testing to a

cancer patient in remission but with high risk of disease recurrence as shown by

the result.

Consultation:

phone: 351 912565038

email: sergejurasunas@hotmail.comSkype: Serge Jurasunas

Blog: Https://naturopathiconcology.blogspot.com.

www. Sergejurasunas.com

Slideshare: www.slideshare.net/SheldonStein